ASX:CSL CSL (CSL) Stock Price, News & Analysis → Wall Street Legend Issues New NVDA Warning (From Chaikin Analytics) (Ad) Free CSL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume869,289 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield1.32%Price TargetN/A Stock AnalysisStock Analysis Get CSL alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About CSL Stock (ASX:CSL)CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.Read More Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. CSL Stock News HeadlinesApril 24, 2024 | afr.comThis fundie says CSL is a $500 stockApril 24, 2024 | msn.comCarlisle Q1 2024 Earnings PreviewApril 25, 2024 | Stansberry Research (Ad)See this before next week's Fed meetingSee this before next week's Fed Meeting Doc Eifrig just released a new video detailing "the perilous moment Americans are in right now." Angry voters, mounting government debt, and blood in the streets… But he's got a way out – a unique way to come out on top no matter who wins this presidential election. (Last time we shared this, it led to a 995% gain.) April 24, 2024 | markets.businessinsider.comTravere Therapeutics Says European Commission Approved Filspari To Treat IgA NephropathyApril 24, 2024 | msn.comEverything We Know About the New BMW M4 CSApril 20, 2024 | msn.comU.S. Could Vaccinate a Fifth of Americans in a Bird Flu EmergencyApril 17, 2024 | finance.yahoo.comMini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL"April 16, 2024 | msn.comCochin Shipyard sets sights on green shipping market in EuropeApril 25, 2024 | Stansberry Research (Ad)See this before next week's Fed meetingSee this before next week's Fed Meeting Doc Eifrig just released a new video detailing "the perilous moment Americans are in right now." Angry voters, mounting government debt, and blood in the streets… But he's got a way out – a unique way to come out on top no matter who wins this presidential election. (Last time we shared this, it led to a 995% gain.) April 12, 2024 | msn.comCarlisle (CSL) Stock Moves -1.19%: What You Should KnowApril 12, 2024 | msn.comCzech opposition tries to hold parliamentary session on PM’s financial affairsApril 11, 2024 | fool.com.auWhy are so many top fundies overweight on CSL shares?April 10, 2024 | msn.comCan the CSL share price really reach $500 in just 3 years?April 9, 2024 | msn.comWhat could $5,000 invested in CSL shares become in 1 year?April 9, 2024 | markets.businessinsider.comWilsons Remains a Hold on CSL (CMXHF)April 8, 2024 | finanznachrichten.dePeak and CSL Join Forces in Europe as Peak CSL GroupApril 3, 2024 | markets.businessinsider.comBuy Rating on Carlisle Companies: Poised for Growth with Strategic Initiatives and Market Position StrengthApril 2, 2024 | finance.yahoo.comCSL Limited (ASX:CSL) On An Uptrend: Could Fundamentals Be Driving The Stock?April 2, 2024 | afr.comWhy picking ASX biotechs is mostly for the crazy braveApril 1, 2024 | fool.com.auCSL share price lower despite US FDA boostApril 1, 2024 | finance.yahoo.comHere’s Why Carlisle Companies Incorporated (CSL) Advanced in Q4March 28, 2024 | msn.comDon't Wait: Motorious Readers Get Double Entries To Win This BMW M4 CSL and BMW MotorcycleMarch 27, 2024 | fool.com.auCSL share price leaping higher amid $1.9 billion funding newsMarch 27, 2024 | markets.businessinsider.comAustralian Stocks: CSL Shares Retain “Strong Buy” Rating from AnalystsMarch 25, 2024 | benzinga.comHere's How Much $100 Invested In Carlisle Companies 10 Years Ago Would Be Worth TodayMarch 21, 2024 | msn.comBMW's Vision Neue Klasse X concept channels 3.0 CSL and E30 vibes, teases next-gen iX3March 20, 2024 | msn.comDo You Think Carlisle Companies Incorporated (CSL) is Misaligned with the UN SDGs?See More Headlines Receive CSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2019Ex-Dividend for 4/2 Dividend3/10/2024Dividend Payable4/02/2024Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:CSL CUSIPN/A CIKN/A Webwww.csl.com.au Phone+61-3-93891911FaxN/AEmployees32,065Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$7.77 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.29Net Income$2.47 billion Net Margins17.43% Pretax MarginN/A Return on Equity13.63% Return on Assets6.41% Debt Debt-to-Equity Ratio63.18 Current Ratio2.15 Quick Ratio1.68 Sales & Book Value Annual Sales$14.18 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow207.70 Book ValueA$35.56 per share Price / BookN/AMiscellaneous Outstanding Shares483,250,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.29 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesDr. Paul F. McKenzie Ph.D. (Age 58)MD, CEO & Executive Director Comp: $4.28MMs. Joy Carolyn Linton B.Com. (Age 59)BComm, GAICD, Grad Dip AFI, Chief Financial Officer Comp: $3.19MMr. Mark DehringHead of Investor RelationsMr. Gregory Boss B.S. (Age 63)BS(Hons), J.D., Executive VP of Legal & General Counsel Comp: $1.7MChristina HickieSenior Manager of CommunicationsMs. Roanne ParryChief Human Resources OfficerDr. Karen Etchberger (Age 66)Executive Vice President of Quality & Business Services Comp: $1.6MMs. Jemimah BrennanHead of Communications - Asia PacificDr. Andrew D. Nash BSc (Hons) (Age 62)GAICD, Ph.D., Senior Vice President of Research Dr. William Mezzanotte M.D. (Age 65)M.P.H., Executive VP & Head of Research and Development Comp: $2.27MMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All CompetitorsInsidersSamantha (Sam) LewisSold 114 sharesTotal: $32,189.95 ($282.37/share)Alison WatkinsSold 169 sharesTotal: $47,996.00 ($284.00/share)Megan ClarkBought 210 shares on 10/20/2023Total: $49,939.05 ($237.81/share)Paul McKenzieSold 44,095 sharesTotal: $10.51 M ($238.24/share)Paul McKenzieSold 3,120 sharesTotal: $839,560.80 ($269.09/share) CSL Stock Analysis - Frequently Asked Questions How were CSL's earnings last quarter? CSL Limited (ASX:CSL) issued its quarterly earnings data on Wednesday, August, 14th. The company reported $4.24 earnings per share for the quarter, topping the consensus estimate of $4.22 by $0.01. CSL had a trailing twelve-month return on equity of 13.63% and a net margin of 17.43%. How often does CSL pay dividends? What is the dividend yield for CSL? CSL announced a Interim dividend on Friday, March 8th. Stockholders of record on Tuesday, April 2nd will be paid a dividend of 1.826 per share on Tuesday, April 2nd. This represents a yield of 0.64%. The ex-dividend date of this dividend is Sunday, March 10th. This is a boost from the stock's previous Interim dividend of A$1.55. Read our dividend analysis for CSL. Is CSL a good dividend stock? CSL (ASX:CSL) pays an annual dividend of A$3.81 per share and currently has a dividend yield of 1.32%. The dividend payout ratio is 49.03%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CSL. What other stocks do shareholders of CSL own? Based on aggregate information from My MarketBeat watchlists, some companies that other CSL investors own include BHP Group (BHP), Commonwealth Bank of Australia (CBA), Cochlear (COH), ResMed (RMD), Telstra Group (TLS), Woodside Petroleum (WPL), Altium (ALU), Afterpay (APT), Appen (APX) and Berkshire Hathaway (BRK.B). This page (ASX:CSL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap Profits“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin Analyticstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
